Insights into adjunctive corticosteroid therapy in fulminant herpes simplex virus encephalitis: case analysis with contrasting outcomes
- PMID: 38981668
- PMCID: PMC11237186
- DOI: 10.47936/encephalitis.2024.00031
Insights into adjunctive corticosteroid therapy in fulminant herpes simplex virus encephalitis: case analysis with contrasting outcomes
Abstract
Herpes simplex virus (HSV) encephalitis, predominantly caused by HSV-1, presents with significant morbidity and mortality challenges. This research investigates the particular role of adjunctive corticosteroid therapy in fulminant HSV encephalitis through in-depth analyses of two contrasting cases. Corticosteroids show potential benefits to improve an exaggerated immune response and limit viral dissemination within the brain. Daily assessments and frequent neuroimaging, particularly using magnetic resonance imaging, aid in the management of fulminant cases. Although existing evidence relies on limited case series and retrospective comparisons, the results of the present study emphasize the necessity for large-scale controlled trials to establish definitive guidelines. The discretion of the treating neurologist governs the decision to implement corticosteroids, emphasizing the imperative need for continued research and evidence-based strategies for this challenging neurological condition.
Keywords: Encephalitis; Steroids; Herpes simplex virus.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures




Similar articles
-
Travel-associated neurological disease terminated in a postmortem diagnosed atypical HSV-1 encephalitis after high-dose steroid therapy - a case report.BMC Infect Dis. 2020 Feb 18;20(1):150. doi: 10.1186/s12879-020-4859-5. BMC Infect Dis. 2020. PMID: 32070282 Free PMC article.
-
Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret's.Herpes. 2004 Jun;11 Suppl 2:57A-64A. Herpes. 2004. PMID: 15319091 Review.
-
Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitis.J Neurovirol. 2000 Feb;6(1):25-32. doi: 10.3109/13550280009006379. J Neurovirol. 2000. PMID: 10786994
-
A Review of the Treatment of Herpes Simplex Virus-1 Encephalitis in Six Immunocompetent Patients.Cureus. 2022 Apr 13;14(4):e24129. doi: 10.7759/cureus.24129. eCollection 2022 Apr. Cureus. 2022. PMID: 35573586 Free PMC article.
-
Understanding Herpes Simplex Virus Type 1 Versus Herpes Simplex Virus Type 2 Encephalitis After Neurosurgery: A Case Series and Literature Review.Surg Infect (Larchmt). 2023 Sep;24(7):583-587. doi: 10.1089/sur.2023.030. Epub 2023 Aug 2. Surg Infect (Larchmt). 2023. PMID: 37527427 Review.
Cited by
-
Herpes simplex virus infection of the central nervous system presenting as a stroke: Case report and review of the literature.IDCases. 2025 Jul 20;41:e02328. doi: 10.1016/j.idcr.2025.e02328. eCollection 2025. IDCases. 2025. PMID: 40735450 Free PMC article.
References
-
- Singh TD, Fugate JE, Hocker S, Wijdicks EF, Aksamit AJ, Jr, Rabinstein AA. Predictors of outcome in HSV encephalitis. J Neurol. 2016;263:277–289. - PubMed
-
- Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013;13:414. - PubMed
-
- AK AK, Bhutta BS, Mendez MD. Herpes Simplex Encephalitis. [Updated 2024 Jan 19]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557643/ - PubMed
Publication types
LinkOut - more resources
Full Text Sources